Oxycodonhydrochlorid G.L. (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodonhydrochlorid G.L., is an opioid analgesic presented as a solid oral dosage form for systemic use. It is employed to manage moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxycodonhydrochlorid G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid that acts within the central nervous system to relieve pain across several clinical contexts. - Acute postoperative pain: Provides strong analgesia during the recovery period after surgery. - Cancer‑related pain: Helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: Used when long‑term opioid therapy is deemed appropriate for conditions such as severe musculoskeletal pain.

Adverse reactions can range from mild to life‑threatening and should be monitored throughout therapy.

Common Side Effects: - Constipation: Reduced gastrointestinal motility leading to hard stools. - Nausea: Sensation of queasiness often accompanied by an urge to vomit. - Drowsiness: Generalized sedation and reduced alertness. - Dry mouth: Decreased salivary secretion causing oral discomfort. - Dizziness: Light‑headed sensation, especially when standing quickly. - Pruritus: Itching without rash.

Serious or Rare Side Effects: - Respiratory depression: Marked reduction in breathing rate that can be fatal. - Severe hypotension: Dangerous drop in blood pressure. - Opioid use disorder: Development of dependence or addiction. - Seizures: Uncommon but potentially life‑threatening convulsions. - Anaphylaxis: Acute allergic reaction with airway compromise. - adrenal insufficiency: Hormonal imbalance affecting stress response.

When prescribing Oxycodone Hydrochloride, clinicians should assess patient history and monitor for adverse events. - Assess renal and hepatic function: Adjust dosing in patients with impairment. - Evaluate risk of respiratory depression: Use lowest effective dose and monitor closely. - Screen for substance‑use disorder: Avoid in patients with active addiction. - Counsel on constipation management: Recommend diet, fluids, and laxatives. - Avoid concurrent CNS depressants: Minimize additive sedation and respiratory effects. - Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Oxycodone Hydrochloride may interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: Combined use can cause profound respiratory depression and sedation. - Central nervous system depressants: Alcohol, barbiturates, or other opioids increase risk of fatal overdose. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): Elevate oxy‑hydroxy‑hydrochloride plasma levels, raising toxicity risk.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): May reduce conversion to active metabolites, affecting analgesia. - Anticholinergic agents: Exacerbate constipation and urinary retention. - Diuretics: May intensify hypotensive effects. - Antihistamines: Increase drowsiness and dizziness. - Serotonergic drugs: Heightened risk of serotonin syndrome.